GLP-1 consumer health products space will be the single biggest launch category of 2025
What to compare Look at included items, ordering flexibility, and total value before deciding which option to take next
Topline Novo Nordisk said Thursday it will sue Hims & Hers after the online pharmaceutical retailer announced a much cheaper, compounded version of the Wegovy weight-loss pilljust over 7 months after Novo Nordisk terminated their distribution agreement, citing concerns over mass-compounding activities, a move that sent the companys stock falling
People should be informed that GLP-1 receptor agonists are not necessarily the problem, but their inappropriate use, or fast and significant weight loss, is
Research about this GLP-1 side effect is still limited, but that doesnt mean its all in peoples heads
Discontinuation is a valid choice when symptoms exceed the benefit